China NRDL 2023 readout: the seven-year itch
The NRDL 2023 appears to be a rather uneventful one, with the process kicked off in July and wrapped up in early December as planned. The official results were announced in mid-December, just in time for all to plan ahead for the new year regardless of the outcome. Here’s our full readout for the China NRDL 2023.
Notably, the 2023 NRDL features a long list of 224 candidates and 126 new inclusions. This breaks a record for the largest round of formulary expansion in the NRDL’s seven-year history.
NRDL new value rating system
Like earlier NRDLs, the candidates consist of a good mix of newly launched innovative drugs, a significant number of me-toos and me-betters, as well as candidates who failed in previous years but made another attempt this year. Unlike earlier NRDLs, each were assigned to one of the four classes per this year’s brand-new value rating system:
